Correcting a handful of misconceptions, inaccuracies and falsehoods in "The blood cancer that became solvable" by Ruxandra Teslo and Amol Punjabi (opens in new tab)

As a fan of Ruxandra Teslo’s writing — 25 mentions to date! — it pains me to write that in “Works in Progress”, for which she shares the byline with chief product officer Amol Punjabi, had me wince about a half-dozen times too many to ignore. Worse yet, I agree with the thrust of the article: that in cell and gene therapy and will soon come for the rest of biomedicine. Heck, that is one of the main reasons I am soon going back to clinical medicine, seeing too many business flights to Shanghai...